Suraksha Diagnostic Ltd vs Take Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Suraksha Diagnostic Ltd is ₹ 298.9 as of 23 Oct 15:30 . The P/E Ratio of Suraksha Diagnostic Ltd changed from 42.2 on March 2025 to 36.9 on March 2026 . This represents a CAGR of -6.49% over 2 yearsThe P/E Ratio of Take Solutions Ltd changed from 2.6 on March 2025 to 54.3 on March 2026 . This represents a CAGR of 357.00% over 2 years The Market Cap of Suraksha Diagnostic Ltd changed from ₹ 1342 crore on March 2025 to ₹ 1187 crore on March 2026 . This represents a CAGR of -5.95% over 2 yearsThe Market Cap of Take Solutions Ltd changed from ₹ 664.96 crore on March 2021 to ₹ 586.26 crore on March 2026 . This represents a CAGR of -2.08% over 6 years The revenue of Suraksha Diagnostic Ltd for the Jun '26 is ₹ 88.73 crore as compare to the Mar '26 revenue of ₹ 82.2 crore. This represent the growth of 7.94% The revenue of Take Solutions Ltd for the Jun '26 is ₹ 31.7 crore as compare to the Mar '26 revenue of ₹ 59.37 crore. This represent the decline of -46.61% The ebitda of Suraksha Diagnostic Ltd for the Jun '26 is ₹ 31.53 crore as compare to the Mar '26 ebitda of ₹ 25.15 crore. This represent the growth of 25.37% The ebitda of Take Solutions Ltd for the Jun '26 is ₹ 1.06 crore as compare to the Mar '26 ebitda of ₹ 4.36 crore. This represent the decline of -75.69% The net profit of Suraksha Diagnostic Ltd changed from ₹ 7.67 crore to ₹ 12.85 crore over 9 quarters. This represents a CAGR of 25.78% The net profit of Take Solutions Ltd changed from ₹ -3.75 crore to ₹ 1.06 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Suraksha Diagnostic Ltd changed from 0.76 % on March 2026 to 0.76 % on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Take Solutions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Suraksha Diagnostic Ltd

Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited' as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata.
Subsequently, Company was converted into a public limited company and the name of Company was changed to Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying out various pathological and radiological testing and medical consultation services in in East India.
In addition to integrated pathology and radiology testing services, it also offer omnichannel medical consultation services via online and offline modes to customers through 43 of its diagnostic centres which house 120 polyclinic chambers hosting 750+ doctors.

About Take Solutions Ltd

Take Solutions Limited was incorporated on December 20, 2000.
The Company has been promoted by a team of domain experts in the supply chain management sector of the software industry. TAKE Solutions delivers domain-intensive services and solutions in Life Sciences, Software and Information Technology.
In the fast-growing Life Sciences space, the Company offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise.
Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers.
As of March 31, 2025, TAKE Solutions Pte Ltd owned 52.90% of the Company's equity share capital and has the ability to control its operating and financial policies. In Supply Chain Management, TAKE through its subsidiaries focuses on niche engineering services, supply chain collaboration and product re-engineering.

FAQs for the comparison of Suraksha Diagnostic Ltd and Take Solutions Ltd

Which company has a larger market capitalization, Suraksha Diagnostic Ltd or Take Solutions Ltd?

Market cap of Suraksha Diagnostic Ltd is 1,556 Cr while Market cap of Take Solutions Ltd is 161 Cr

What are the key factors driving the stock performance of Suraksha Diagnostic Ltd and Take Solutions Ltd?

The stock performance of Suraksha Diagnostic Ltd and Take Solutions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Suraksha Diagnostic Ltd and Take Solutions Ltd?

As of October 25, 2026, the Suraksha Diagnostic Ltd stock price is INR ₹298.9. On the other hand, Take Solutions Ltd stock price is INR ₹10.93.

How do dividend payouts of Suraksha Diagnostic Ltd and Take Solutions Ltd compare?

To compare the dividend payouts of Suraksha Diagnostic Ltd and Take Solutions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.